Pregabalin Eases Pain from Diabetic Neuropathy
A review of previous studies showed that pregabalin (Lyrica), a drug used for epileptic attacks, could safely and effectively relieve pain from diabetic neuropathy. Published in the journal Diabetes Care, the analysis of seven studies on pregabalin, with dosages of 150, 300, and 600 mg and study durations from five to 13 weeks, showed that “pregabalin significantly reduced pain and pain-related sleep interference,” said researchers from the Harvard Medical School in Boston.
All three dosages were divided into three pills taken throughout the day. However, the researchers note that only the highest dose was effective when divided into two pills. Results showed that the 150 and 300 mg doses took five days and 13 days respectively before a sustained pain reduction. On the other hand, the 600 mg typically took four days to take effect; unfortunately, it was also the one most likely to cause side effects — dizziness, sleepiness, and swelling in the arms and legs. Weight gain, which was experienced by some of the patients, was also directly associated with the dose of pregabalin and duration of the treatment. However, this unexplained weight gain did not affect the patients’ ability to control their blood sugar levels, according to researchers.
- King Fahd Medical City
The King Fahd Medical City (KFMC) is a medical compound comprise of four hospitals to wit: Main hospitals, maternity hospital, pediatric hospital, rehabilitation center, which makes up for its 1,095 bed capacity. In addition, there [...]
- Ankle Mobility Impaired in Diabetes
A new study has proven that people with long-standing diabetes are prone to impairment of their ankle function despite not having peripheral neuropathy. Peripheral neuropathy, which is linked to diabetes, is a progressive deterioration of [...]
- What is the Difference between Adult and Juvenile Diabetes?
What is diabetes mellitus? The glucose or sugar that your body gets from eating carbohydrates is delivered to your bloodstream and then to the cells. Glucose is then converted to energy which enables us to [...]
- NURSING RESPONSIBILITY IN ADMINISTRATION OF MEDICATIONS WITH NARROW MARGIN OF SAFETY
Calling all Nurses & Nurses with IV Theraphy License WHEN: JULY 2, 2010 (FRIDAY) TIME: 1PM TO 6PM WHERE: HBD INSTITUTE, Philippine College of Surgeon Bldg. Ground floor #992 North EDSA Qeuzon City.(in-front of SM north annex [...]
- US FDA Approved New Diabetes Drug
There's a new diabetes drug on the block. Januvia (sitagliptin), from Merck and Co. Inc., received approval from the United States Food and Drug Administration (US FDS) recently, making it as the newset oral [...]